Mazindol (AN-448) : a new non-amphetamine anorectic in the treatment of exogenous obesity
Delitala, G.; Alagna, S.; Masala, A.
La Clinica Terapeutica 81(6): 547-554
1977
ISSN/ISBN: 0009-9074 PMID: 884939 Document Number: 122086
Document emailed within 1 workday
Related Documents
Siani, V. 1978: Mazindol: a new anorectic drug La Clinica Terapeutica 84(1): 100-101Mattei, R.; Carlini, E.A. 1995: Mazindol: anorectic and behavioral effects in female rats Archives Internationales de Pharmacodynamie et de Therapie 330(3): 279-287
Felt, V. 1976: Treatment of obesity using a new anorectic Vnitrni Lekarstvi 22(4): 371-374
Abdallah, A.H. 1971: On the role of norepinephrine in the anorectic effect of D-amphetamine in mice Archives Internationales de Pharmacodynamie et de Therapie 192(1): 72-77
Abdallah, A.; White, H.D. 1970: Comparative study of the anorectic activity of phenindamine d-amphetamine and fenfluramine in different species Archives Internationales de Pharmacodynamie et de Therapie 188(2): 271-283
Komorowski, J.M.; Zwaigzne-Raczyńska, J.; Owczarczyk, I.; Gołebiowska, M.; Zarzycki, J. 1982: Effect of mazindol (teronac) on various hormonal indicators in children with simple obesity Pediatria Polska 57(4): 241-246
Stepanek, J.; Zolliker, V.R. 1971: Circulatory effects of the anorectic Diphemethoxidine compared with the effects of Amphetamine and Aminorex Archives Internationales de Pharmacodynamie et de Therapie 191(2): 376-399
Turatti, S.; de Netto, G.A. 1970: Treatment of exogenous obesity: use of delayed action dimethylphenethylamine Revista Brasileira de Medicina 27(1): 57-63
Kawano-Takahashi, Y.; Ohminaji, H.; Ubagai, E.; Okuda, H. 1984: Mechanisms of action of mazindol in preventing onset and development of obesity induced by gold thioglucose injection International Journal of Obesity 8(6): 655-664
Langlois, K.J.; Forbes, J.A.; Bell, G.W.; Grant, G.F. 1974: A double-blind clinical evaluation of the safety and efficacy of phentermine hydrochloride (Fastin) in the treatment of exogenous obesity Current Therapeutic Research 16(4): 289-296
Schmitt, T.; Luqman, W.; McCool, C.; Lenz, F.; Ahmad, U.; Nolan, S.; Stephan, T.; Sunder, J.H.; Danowski, T.S. 1977: Unresponsiveness to exogenous TSH in obesity International Journal of Obesity 1(2): 185-190
Spesivtseva, V.G. 1978: Exogenous, constitutional obesity Sovetskaia Meditsina 6: 27-32
Fireman, A.E. 1977: Obesity (exogenous) is not a medical problem Journal of the Florida Medical Association 64(9): 657-658
Brondarenko, I.M. 1978: Urine sodium and potassium in children with constitutional exogenous obesity Pediatriia 9: 42-43
Vlasova, I.I.; Ametov, A.S. 2010: The role of hypothalomo-pituitary-adrenal system in pathogenesis of exogenous-constitutional obesity Klinicheskaia Meditsina 88(4): 48-52
Matter, M.; Cavin, R. 1993: Mason's gastroplasty for exogenous morbid obesity: results and commentaries apropos of 33 patients Revue Medicale de la Suisse Romande 113(8): 621-624
Macarone-Palmieri, R.; Boumghar, M.; Chapuis, G.; Ryncki, P.V.; Saegesser, R.F. 1978: Short-term follow-up of patients treated for exogenous morbid obesity by means of jejuno-ileal by-pass Schweizerische Rundschau für Medizin Praxis 67(5): 150-156
Merzlikina, N.L.; Romantsova, T.I.; Roik, O.V.; Lobanova, N.A.; Drapkina, O.M.; Ivashkin, V.T. 2009: Assessment of external breathing parameters and cardiovascular function in patients with constitutive exogenous obesity and reduced body weight Klinicheskaia Meditsina 87(1): 40-45
Kalivas, P.W.; Weber, B. 1988: Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine Journal of Pharmacology and Experimental Therapeutics 245(3): 1095-1102
Verdy, M.; Charbonneau, L.; Verdy, I.; Belanger, R.; Bolte, E.; Chiasson, J.L. 1983: Fenfluramine in the treatment of non-insulin-dependent diabetics: hypoglycemic versus anorectic effect International Journal of Obesity 7(4): 289-297